# | Title | Link | Authors | Cite | PMID | Abstract |
|---|---|---|---|---|---|---|
1 | Treatment for COVID-19: An overview. | https://pubmed.ncbi.nlm.nih.gov/33053381/ | Stasi C, Fallani S, Voller F, Silvestri C. | Eur J Pharmacol. 2020 Dec 15;889:173644. doi: 10.1016/j.ejphar.2020.173644. Epub 2020 Oct 11. | 33053381 | Coronavirus disease 2019 (COVID-19) is an infectious disease caused by coronavirus-2 (SARS-CoV-2) that causes a severe acute respiratory syndrome, a characteristic hyperinflammatory response, vascular damage, microangiopathy, angiogenesis and wi … |
2 | Characteristics of SARS-CoV-2 and COVID-19. | https://pubmed.ncbi.nlm.nih.gov/33024307/ | Hu B, Guo H, Zhou P, Shi ZL. | Nat Rev Microbiol. 2021 Mar;19(3):141-154. doi: 10.1038/s41579-020-00459-7. Epub 2020 Oct 6. | 33024307 | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute respiratory disease, named 'coronavirus disease 2019' (COVID-19), whic … |
3 | Pathological sequelae of long-haul COVID. | https://pubmed.ncbi.nlm.nih.gov/35105985/ | Mehandru S, Merad M. | Nat Immunol. 2022 Feb;23(2):194-202. doi: 10.1038/s41590-021-01104-y. Epub 2022 Feb 1. | 35105985 | The world continues to contend with successive waves of coronavirus disease 2019 (COVID-19), fueled by the emergence of viral variants. At the same time, persistent, prolonged and often debilitating sequelae are increasingly recognized in convalescent individuals, n … |
4 | SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. | https://pubmed.ncbi.nlm.nih.gov/35163638/ | Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. | Int J Mol Sci. 2022 Feb 2;23(3):1716. doi: 10.3390/ijms23031716. | 35163638 | The review aims to consolidate research findings on the molecular mechanisms and virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the … |
5 | COVID-19: Virology, biology and novel laboratory diagnosis. | https://pubmed.ncbi.nlm.nih.gov/33305456/ | Mohamadian M, Chiti H, Shoghli A, Biglari S, Parsamanesh N, Esmaeilzadeh A. | J Gene Med. 2021 Feb;23(2):e3303. doi: 10.1002/jgm.3303. Epub 2021 Jan 6. | 33305456 | BACKGROUND: At the end of December 2019, a novel coronavirus tentatively named SARS-CoV-2 in Wuhan, a central city in China, was announced by the World Health Organization. ...DISCUSSION: SARS-CoV-2 infected patients usually present with … |